Doctors seek best first treatment for Kids' hair loss
NCT ID NCT07381556
Summary
This study aims to find out which of two common medications works better for children with moderate-to-severe alopecia areata, a condition causing patchy or total hair loss. Children and teens (ages 2-17) starting their first systemic treatment will choose, with their parents, to take either cyclosporine or methotrexate. Researchers will track hair regrowth and quality of life over 9 months to see which medicine provides better results in real-world care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA (AA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Erasmus MC
RECRUITINGRotterdam, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.